Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease

NCT02437422 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency, Chronic

Interventions

BIOLOGICAL: SANGUINATE

Sponsor

Prolong Pharmaceuticals